154 related articles for article (PubMed ID: 37760964)
21. Meaningful values of the EQ-5D-3L in patients undergoing primary knee arthroplasty.
Yapp LZ; Scott CEH; Howie CR; MacDonald DJ; Simpson AHRW; Clement ND
Bone Joint Res; 2022 Sep; 11(9):619-628. PubMed ID: 36047008
[TBL] [Abstract][Full Text] [Related]
22. Validity, responsiveness and minimal important change of the EQ-5D-5L in patients after rotator cuff repair, shoulder arthroplasty or thumb carpometacarpal arthroplasty.
Marks M; Grobet C; Audigé L
Qual Life Res; 2021 Oct; 30(10):2973-2982. PubMed ID: 33973108
[TBL] [Abstract][Full Text] [Related]
23. Assessing health-related quality-of-life in patients with symptomatic obstructive hypertrophic cardiomyopathy: EQ-5D-based utilities in the EXPLORER-HCM trial.
Xie J; Wang Y; Xu Y; Fine JT; Lam J; Garrison LP
J Med Econ; 2022; 25(1):51-58. PubMed ID: 34907813
[TBL] [Abstract][Full Text] [Related]
24. Measuring the Time to Deterioration for Health-Related Quality of Life in Patients With Metastatic Breast Cancer Using a Web-Based Monitoring Application: Longitudinal Cohort Study.
Brusniak K; Feisst M; Sebesteny L; Hartkopf A; Graf J; Engler T; Schneeweiss A; Wallwiener M; Deutsch TM
JMIR Cancer; 2021 Oct; 7(4):e25776. PubMed ID: 34636732
[TBL] [Abstract][Full Text] [Related]
25. An analysis of Euroqol EQ-5D and Manchester Oxford Foot Questionnaire scores six months following podiatric surgery.
Maher AJ; Kilmartin TE
J Foot Ankle Res; 2012 Jul; 5(1):17. PubMed ID: 22776703
[TBL] [Abstract][Full Text] [Related]
26. A longitudinal validation of the EQ-5D-5L and EQ-VAS stand-alone component utilising the Oxford Hip Score in the Australian hip arthroplasty population.
Lin DY; Cheok TS; Samson AJ; Kaambwa B; Brown B; Wilson C; Kroon HM; Jaarsma RL
J Patient Rep Outcomes; 2022 Jun; 6(1):71. PubMed ID: 35723750
[TBL] [Abstract][Full Text] [Related]
27. The health gap and HRQoL inequalities in Greece before and during the economic crisis.
Yfantopoulos J; Chantzaras A; Yfantopoulos P
Front Public Health; 2023; 11():1138982. PubMed ID: 37342272
[TBL] [Abstract][Full Text] [Related]
28. A pilot study on the validity and psychometric properties of the electronic EQ-5D-5L in routine clinical practice.
Lam CLK; Tse ETY; Wong CKH; Lam JSM; Chen SS; Bedford LE; Cheung JPY; Or CK; Kind P
Health Qual Life Outcomes; 2021 Dec; 19(1):266. PubMed ID: 34922564
[TBL] [Abstract][Full Text] [Related]
29. Comparison between EQ-5D-5L and PROMIS-10 to evaluate health-related quality of life 3 months after stroke: a cross-sectional multicenter study.
DE Graaf JA; Visser-Meily JM; Schepers VP; Baars A; Kappelle LJ; Passier PE; Wermer MJ; DE Wit DC; Post MW
Eur J Phys Rehabil Med; 2021 Jun; 57(3):337-346. PubMed ID: 33448750
[TBL] [Abstract][Full Text] [Related]
30. Validity of EQ-5D utility index and minimal clinically important difference estimation among patients with chronic obstructive pulmonary disease.
Bae E; Choi SE; Lee H; Shin G; Kang D
BMC Pulm Med; 2020 Mar; 20(1):73. PubMed ID: 32293387
[TBL] [Abstract][Full Text] [Related]
31. Validity and responsiveness of EQ-5D-5L and SF-6D in patients with health complaints attributed to their amalgam fillings: a prospective cohort study of patients undergoing amalgam removal.
Lamu AN; Björkman L; Hamre HJ; Alræk T; Musial F; Robberstad B
Health Qual Life Outcomes; 2021 Apr; 19(1):125. PubMed ID: 33865400
[TBL] [Abstract][Full Text] [Related]
32. Health-related quality of life in amyotrophic lateral sclerosis using EQ-5D-5L.
Wei QQ; Hou Y; Chen Y; Ou R; Cao B; Zhang L; Yang T; Shang H
Health Qual Life Outcomes; 2021 Jul; 19(1):181. PubMed ID: 34284776
[TBL] [Abstract][Full Text] [Related]
33. Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung disease.
Tsai APY; Hur SA; Wong A; Safavi M; Assayag D; Johannson KA; Morisset J; Fell C; Fisher JH; Manganas H; Shapera S; Cox G; Gershon AS; Hambly N; Khalil N; To T; Wilcox PG; Halayko A; Kolb MR; Ryerson CJ
Thorax; 2021 Jan; 76(1):37-43. PubMed ID: 33023996
[TBL] [Abstract][Full Text] [Related]
34. Validity of an enhanced EQ-5D-5L measure with an added cognitive dimension in patients with stroke.
de Graaf JA; Kuijpers M; Visser-Meily J; Kappelle LJ; Post M
Clin Rehabil; 2020 Apr; 34(4):545-550. PubMed ID: 32070131
[TBL] [Abstract][Full Text] [Related]
35. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
[TBL] [Abstract][Full Text] [Related]
36. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.
McCaffrey N; Kaambwa B; Currow DC; Ratcliffe J
Health Qual Life Outcomes; 2016 Sep; 14(1):133. PubMed ID: 27644755
[TBL] [Abstract][Full Text] [Related]
37. Validation and comparison of 15-D and EQ-5D-5L instruments in a Spanish Parkinson's disease population sample.
García-Gordillo M; del Pozo-Cruz B; Adsuar JC; Sánchez-Martínez FI; Abellán-Perpiñán JM
Qual Life Res; 2014 May; 23(4):1315-26. PubMed ID: 24258254
[TBL] [Abstract][Full Text] [Related]
38. A cross sectional survey on health-related quality of life among parents of children with allergic symptoms using the EQ-5D-5L.
Hwang TY; Kim SK; Kim SH; Kim M
J Asthma; 2019 Nov; 56(11):1239-1245. PubMed ID: 30702001
[No Abstract] [Full Text] [Related]
39. Determination of minimum clinically important difference in pain, disability, and quality of life after extension of fusion for adjacent-segment disease.
Parker SL; Mendenhall SK; Shau D; Adogwa O; Cheng JS; Anderson WN; Devin CJ; McGirt MJ
J Neurosurg Spine; 2012 Jan; 16(1):61-7. PubMed ID: 21962034
[TBL] [Abstract][Full Text] [Related]
40. Validity and reliability of EQ-5D-5L among patients with axial spondyloarthritis in Singapore.
Seng JJB; Kwan YH; Fong W; Phang JK; Lui NL; Thumboo J; Leung YY
Eur J Rheumatol; 2020 Apr; 7(2):71-78. PubMed ID: 32644927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
